194 related articles for article (PubMed ID: 16141187)
21. Effect of trilostane on hormone and serum electrolyte concentrations in dogs with pituitary-dependent hyperadrenocorticism.
Griebsch C; Lehnert C; Williams GJ; Failing K; Neiger R
J Vet Intern Med; 2014; 28(1):160-5. PubMed ID: 24341822
[TBL] [Abstract][Full Text] [Related]
22. Comparison of adrenocorticotropic hormone stimulation test results started 2 versus 4 hours after trilostane administration in dogs with naturally occurring hyperadrenocorticism.
Bonadio CM; Feldman EC; Cohen TA; Kass PH
J Vet Intern Med; 2014; 28(4):1239-43. PubMed ID: 24863172
[TBL] [Abstract][Full Text] [Related]
23. Trilostane therapy for treatment of pituitary-dependent hyperadrenocorticism in 5 cats.
Neiger R; Witt AL; Noble A; German AJ
J Vet Intern Med; 2004; 18(2):160-4. PubMed ID: 15058766
[TBL] [Abstract][Full Text] [Related]
24. Trilostane treatment of bilateral adrenal enlargement and excessive sex steroid hormone production in a cat.
Boag AK; Neiger R; Church DB
J Small Anim Pract; 2004 May; 45(5):263-6. PubMed ID: 15163055
[TBL] [Abstract][Full Text] [Related]
25. Canine hyperadrenocorticism: effects of trilostane on parathyroid hormone, calcium and phosphate concentrations.
Tebb AJ; Arteaga A; Evans H; Ramsey IK
J Small Anim Pract; 2005 Nov; 46(11):537-42. PubMed ID: 16300115
[TBL] [Abstract][Full Text] [Related]
26. The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism.
Oda H; Mori A; Shono S; Onozawa E; Sako T
J Vet Med Sci; 2016 Jun; 78(5):851-4. PubMed ID: 26782012
[TBL] [Abstract][Full Text] [Related]
27. Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs.
Macfarlane L; Parkin T; Ramsey I
Vet Rec; 2016 Dec; 179(23):597. PubMed ID: 27803375
[TBL] [Abstract][Full Text] [Related]
28. Adrenal necrosis in a dog receiving trilostane for the treatment of hyperadrenocorticism.
Chapman PS; Kelly DF; Archer J; Brockman DJ; Neiger R
J Small Anim Pract; 2004 Jun; 45(6):307-10. PubMed ID: 15206477
[TBL] [Abstract][Full Text] [Related]
29. Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat.
Skelly BJ; Petrus D; Nicholls PK
J Small Anim Pract; 2003 Jun; 44(6):269-72. PubMed ID: 12831104
[TBL] [Abstract][Full Text] [Related]
30. A comparison of once and twice daily administration of trilostane to dogs with hyperadrenocorticism.
Augusto M; Burden A; Neiger R; Ramsey I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(6):415-24. PubMed ID: 23242222
[TBL] [Abstract][Full Text] [Related]
31. Histological evaluation of the adrenal glands of seven dogs with hyperadrenocorticism treated with trilostane.
Reusch CE; Sieber-Ruckstuhl N; Wenger M; Lutz H; Perren A; Pospischil A
Vet Rec; 2007 Feb; 160(7):219-24. PubMed ID: 17308018
[TBL] [Abstract][Full Text] [Related]
32. Persistent isolated hypocortisolism following brief treatment with trilostane.
Ramsey IK; Richardson J; Lenard Z; Tebb AJ; Irwin PJ
Aust Vet J; 2008 Dec; 86(12):491-5. PubMed ID: 19076773
[TBL] [Abstract][Full Text] [Related]
33. Determination of the concentrations of trilostane and ketotrilostane that inhibit ex vivo canine adrenal gland synthesis of cortisol, corticosterone, and aldosterone.
McGraw AL; Whitley EM; Lee HP; Boothe DM; Behrend EN
Am J Vet Res; 2011 May; 72(5):661-5. PubMed ID: 21529218
[TBL] [Abstract][Full Text] [Related]
34. Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism.
Galac S; Buijtels JJCWM; Mol JA; Kooistra HS
Vet J; 2010 Jan; 183(1):75-80. PubMed ID: 19042143
[TBL] [Abstract][Full Text] [Related]
35. Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
Vet Rec; 2008 Oct; 163(16):477-81. PubMed ID: 18931355
[TBL] [Abstract][Full Text] [Related]
36. Comparison of non-selective adrenocorticolysis with mitotane or trilostane for the treatment of dogs with pituitary-dependent hyperadrenocorticism.
Clemente M; De Andrés PJ; Arenas C; Melián C; Morales M; Pérez-Alenza MD
Vet Rec; 2007 Dec; 161(24):805-9. PubMed ID: 18083978
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism.
Aldridge C; Behrend EN; Kemppainen RJ; Lee-Fowler TM; Martin LG; Ward CR; Bruyette D; Pannu J; Gaillard P; Lee HP
J Vet Intern Med; 2016 Sep; 30(5):1637-1641. PubMed ID: 27425787
[TBL] [Abstract][Full Text] [Related]
38. Old or new? A comparison of mitotane and trilostane for the management of hyperadrenocorticism.
Griffies JD
Compend Contin Educ Vet; 2013 May; 35(5):E3. PubMed ID: 23677783
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog.
Park SM; Kim KB; Song WJ; Youn HY
Vet Med Sci; 2021 Jul; 7(4):1150-1153. PubMed ID: 33755348
[TBL] [Abstract][Full Text] [Related]
40. Cortisol Concentrations in Well-Regulated Dogs with Hyperadrenocorticism Treated with Trilostane.
Midence JN; Drobatz KJ; Hess RS
J Vet Intern Med; 2015; 29(6):1529-33. PubMed ID: 26374943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
